Resultats de la cerca - Lynsey M. Whilding

  • Mostrar 1 - 13 resultats de 13
Refinar resultats
  1. 1
    CAR T‐cell immunotherapy: The path from the by‐road to the freeway?

    CAR T‐cell immunotherapy: The path from the by‐road to the freeway? per Lynsey M. Whilding, John Maher

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

    CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth per Ru Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy, Lynsey M. Whilding, Artemis Gavrill, John Maher, Pinku Mukherjee

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Vaccinia Virus Induces Programmed Necrosis in Ovarian Cancer Cells

    Vaccinia Virus Induces Programmed Necrosis in Ovarian Cancer Cells per Lynsey M. Whilding, Kyra M. Archibald, Hagen Kulbe, Frances R. Balkwill, Daniel Öberg, Iain A. McNeish

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies

    CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies per Lynsey M. Whilding, Leena Halim, Benjamin Draper, Ana C. Parente‐Pereira, Tomasz Zabinski, David M. Davies, John Maher

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer

    Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer per Christian J. Maine, Nor Haslinda Abd Aziz, Jayanta Chatterjee, Claudia Hayford, Nancy Brewig, Lynsey M. Whilding, Andrew J.T. George, Sadaf Ghaem‐Maghami

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin

    Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin per Ana C. Parente‐Pereira, Lynsey M. Whilding, Nancy Brewig, Sjoukje J. C. van der Stegen, David M. Davies, Scott Wilkie, May C I van Schalkwyk, Sadaf Ghaem‐Maghami, John Maher

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Clinical Use of Programmed Cell Death-1 and Its Ligand Expression as Discriminatory and Predictive Markers in Ovarian Cancer

    Clinical Use of Programmed Cell Death-1 and Its Ligand Expression as Discriminatory and Predictive Markers in Ovarian Cancer per Jayanta Chatterjee, Wei Dai, Nor Haslinda Abd Aziz, Pei Y. Teo, John Wahba, David L. Phelps, Christian J. Maine, Lynsey M. Whilding, Roberto Dina, Giorgia Trevisan, Kirsty Flower, Andrew J.T. George, Sadaf Ghaem‐Maghami

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    CAR T-cell immunotherapy of MET-expressing malignant mesothelioma

    CAR T-cell immunotherapy of MET-expressing malignant mesothelioma per Thivyan Thayaparan, Roseanna M. Petrovic, Daniela Achkova, Tomasz Zabinski, David M. Davies, Astero Klampatsa, Ana C. Parente‐Pereira, Lynsey M. Whilding, Sjoukje JC van der Stegen, Natalie Woodman, Michael Sheaff, Jennifer R. Cochran, James Spicer, John Maher

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity?

    Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity? per Sjoukje J. C. van der Stegen, David M. Davies, Scott Wilkie, Julie Foster, Jane Sosabowski, Jerome Burnet, Lynsey M. Whilding, Roseanna M. Petrovic, Sadaf Ghaem‐Maghami, Stephen J. Mather, Jean‐Pierre Jeannon, Ana C. Parente‐Pereira, John Maher

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Adoptive Immunotherapy of Epithelial Ovarian Cancer with Vγ9Vδ2 T Cells, Potentiated by Liposomal Alendronic Acid

    Adoptive Immunotherapy of Epithelial Ovarian Cancer with Vγ9Vδ2 T Cells, Potentiated by Liposomal Alendronic Acid per Ana C. Parente‐Pereira, Hilary Shmeeda, Lynsey M. Whilding, Constantinos P. Zambirinis, Julie Foster, Sjoukje J. C. van der Stegen, Richard Beatson, Tomasz Zabinski, Nancy Brewig, Jane Sosabowski, Stephen J. Mather, Sadaf Ghaem‐Maghami, Alberto Gabizón, John Maher

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells

    Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells per Lynsey M. Whilding, Ana C. Parente‐Pereira, Tomasz Zabinski, David M. Davies, Roseanna M. Petrovic, Y. Vincent Kao, Shobhit Saxena, Alex Romain, Jose A. Costa-Guerra, Shelia M. Violette, Hiroaki Itamochi, Sadaf Ghaem‐Maghami, Sabari Vallath, John F. Marshall, John Maher

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Errata/Corrigenda
    Afegir a favorits
    Guardat en:
  12. 12
    Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells

    Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells per Lynsey M. Whilding, Ana C. Parente‐Pereira, Tomasz Zabinski, David M. Davies, Roseanna M. Petrovic, Y. Vincent Kao, Shobhit Saxena, Alex Romain, Jose A. Costa-Guerra, Shelia M. Violette, Hiroaki Itamochi, Sadaf Ghaem‐Maghami, Sabari Vallath, John F. Marshall, John Maher

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors

    Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors per Tamara Muliaditan, Leena Halim, Lynsey M. Whilding, Benjamin Draper, Daniela Achkova, Fahima Kausar, Maya Glover, Natasha Bechman, Appitha Arulappu, Jenifer Sanchez, Katie R Flaherty, Jana Obajdin, Kristiana Grigoriadis, Pierre Antoine, Daniel Larcombe-Young, Caroline Hull, Richard Buus, Peter M. Gordon, Anita Grigoriadis, David M. Davies, Anna Schurich, John Maher

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: